English

INTERMOLECULAR INC

EDGAR

IMI Quarterly report (10-Q) · filed 2019-08-08

38 filing records in this dataset, filed from 2011-07-29 to 2019-08-08. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.62 million USD

2019 Q2 · USD

Exact inputs and evidence

Revenue: 4618000 USD Source

Operating margin

-119.16%

2019 Q2 · %

Exact inputs and evidence

Operating Income: -5503000 USD Source
Revenue: 4618000 USD Source

Operating cash flow

-3.11 million USD

2019 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -6020000 USD Source
Operating Cash Flow: -2915000 USD Source

Free cash flow

-3.55 million USD

2019 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -6020000 USD Source
Operating Cash Flow: -2915000 USD Source
Capital Expenditure: 574000 USD Source
Capital Expenditure: 134000 USD Source

Cash and cash equivalents: 2.16 million USD 2019-06-30 Source
Exact value

2160000 USD
Long-term debt including current maturities: 23 million USD 2014-12-31 Source
Exact value

23000000 USD
Shares outstanding: 49.8 million shares 2019-06-30 Source
Exact value

49758224 shares

Reported share-count change

0.04% · 21.5 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

49736705 shares · 2018-06-30· Source
49758224 shares · 2019-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2019-08-08.

Financial data available through: 2018-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2018-12-31
Operating income: 9 of 11 periods available· newest 2018-12-31
Net income: 9 of 11 periods available· newest 2018-12-31
Operating cash flow: 9 of 11 periods available· newest 2018-12-31
Capital expenditure: 9 of 11 periods available· newest 2018-12-31
Total assets: 8 of 11 periods available· newest 2018-12-31
Total liabilities: 8 of 11 periods available· newest 2018-12-31
Current assets: 8 of 11 periods available· newest 2018-12-31
Current liabilities: 8 of 11 periods available· newest 2018-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2018-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2014-12-31
Shares outstanding: 8 of 11 periods available· newest 2018-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-9.5%

Prior period

USD 37.2 million

2017-01-01 – 2017-12-31
Current period

USD 33.66 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

33660000 − 37203000 = -3543000 USD

37203000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
33660000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Year-over-year change in Revenue: -3543000 USD Concept: fundies:Revenue Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 33660000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#112751 Filing: 000156459019007009 Input fundies:Revenue: 37203000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#112980 Filing: 000156459019007009
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 6.99 million

Prior period

−USD 10.4 million

2017-01-01 – 2017-12-31
Current period

−USD 3.41 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

-3411000 − -10403000 = 6992000 USD

-10403000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-3411000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Year-over-year change in Net income: 6992000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3411000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#118703 Filing: 000156459019007009 Input fundies:NetIncome: -10403000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#118856 Filing: 000156459019007009
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 6.81 million

Prior period

−USD 873,000

2017-01-01 – 2017-12-31
Current period

USD 5.94 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

5938000 − -873000 = 6811000 USD

-873000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
5938000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Year-over-year change in Operating cash flow: 6811000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 5938000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#135571 Filing: 000156459019007009 Input fundies:OperatingCashFlow: -873000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#135781 Filing: 000156459019007009
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+65.6%

Prior period

USD 777,000

2017-01-01 – 2017-12-31
Current period

USD 1.29 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

1287000 − 777000 = 510000 USD

777000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
1287000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Year-over-year change in Capital expenditure: 510000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1287000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#136799 Filing: 000156459019007009 Input fundies:CapitalExpenditure: 777000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#137009 Filing: 000156459019007009
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2018 2018-01-01 – 2018-12-31

Revenue USD 33.66 million 100% of revenue
Cost of revenue USD 10.01 million 30% of revenue
Operating expenses USD 28 million 83% of revenue
Operating income −USD 4.35 million −13% of revenue
Tax, interest and other Derived −USD 937,000 −2.8% of revenue
Net income −USD 3.41 million −10% of revenue

Cash

Operating cash flow USD 5.94 million 18% of revenue
Capital expenditure USD 1.29 million 3.8% of revenue
Free cash flow Derived USD 4.65 million 14% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Operating loss: operating costs were 105% of revenue.
2011 Operating loss: operating costs were 107% of revenue.
2012 Net loss: net income was −1.1% of revenue.
2013 Operating loss: operating costs were 112% of revenue.
2014 Operating loss: operating costs were 144% of revenue.
2015 Operating loss: operating costs were 146% of revenue.
2016 Operating loss: operating costs were 134% of revenue.
2017 Operating loss: operating costs were 130% of revenue.
2018 Operating loss: operating costs were 113% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	42674000	44678000 Derived	-2004000	-226000 Derived	-1778000	-9342000 Derived	Source 2010-01-01 – 2010-12-31: 42674000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2004000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -1778000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 1175000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 10517000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	53830000	57548000 Derived	-3718000	26297000 Derived	-30015000	-20962000 Derived	Source 2011-01-01 – 2011-12-31: 53830000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -3718000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -30015000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -8156000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 12806000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	66827000	66543000 Derived	284000	1040000 Derived	-756000	-3074000 Derived	Source 2012-01-01 – 2012-12-31: 66827000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 284000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -756000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 3486000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 6560000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	67406000	75435000 Derived	-8029000	790000 Derived	-8819000	-5755000 Derived	Source 2013-01-01 – 2013-12-31: 67406000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -8029000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -8819000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 7779000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 13534000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	47695000	68738000 Derived	-21043000	718000 Derived	-21761000	-4665000 Derived	Source 2014-01-01 – 2014-12-31: 47695000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -21043000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -21761000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -1850000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 2815000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	45322000	66048000 Derived	-20726000	287000 Derived	-21013000	-6279000 Derived	Source 2015-01-01 – 2015-12-31: 45322000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -20726000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -21013000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -4827000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 1452000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	47298000	63166000 Derived	-15868000	-431000 Derived	-15437000	-7785000 Derived	Source 2016-01-01 – 2016-12-31: 47298000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -15868000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -15437000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -5404000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 2381000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	37203000	48208000 Derived	-11005000	-602000 Derived	-10403000	-1650000 Derived	Source 2017-01-01 – 2017-12-31: 37203000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -11005000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -10403000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -873000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 777000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	33660000	38008000 Derived	-4348000	-937000 Derived	-3411000	4651000 Derived	Source 2018-01-01 – 2018-12-31: 33660000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -4348000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -3411000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 5938000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1287000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 33.7M 2018

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Revenue	42674000	Revenue: 42674000 Open source
20112011-12-31	Revenue	53830000	Revenue: 53830000 Open source
20122012-12-31	Revenue	66827000	Revenue: 66827000 Open source
20132013-12-31	Revenue	67406000	Revenue: 67406000 Open source
20142014-12-31	Revenue	47695000	Revenue: 47695000 Open source
20152015-12-31	Revenue	45322000	Revenue: 45322000 Open source
20162016-12-31	Revenue	47298000	Revenue: 47298000 Open source
20172017-12-31	Revenue	37203000	Revenue: 37203000 Open source
20182018-12-31	Revenue	33660000	Revenue: 33660000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-9.5% 2018

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Year over year	No prior comparable period	Revenue: 42674000 Open source
20112011-12-31	Year over year	26.1%	Revenue: 53830000 Open source Revenue: 42674000 Open source
20122012-12-31	Year over year	24.1%	Revenue: 66827000 Open source Revenue: 53830000 Open source
20132013-12-31	Year over year	0.9%	Revenue: 67406000 Open source Revenue: 66827000 Open source
20142014-12-31	Year over year	-29.2%	Revenue: 47695000 Open source Revenue: 67406000 Open source
20152015-12-31	Year over year	-5%	Revenue: 45322000 Open source Revenue: 47695000 Open source
20162016-12-31	Year over year	4.4%	Revenue: 47298000 Open source Revenue: 45322000 Open source
20172017-12-31	Year over year	-21.3%	Revenue: 37203000 Open source Revenue: 47298000 Open source
20182018-12-31	Year over year	-9.5%	Revenue: 33660000 Open source Revenue: 37203000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -12.9% 2018

Net margin -10.1% 2018

Free cash flow margin 13.8% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Operating margin	-4.7%	Operating Income: -2004000 Open source Revenue: 42674000 Open source
20112011-12-31	Operating margin	-6.9%	Operating Income: -3718000 Open source Revenue: 53830000 Open source
20122012-12-31	Operating margin	0.4%	Operating Income: 284000 Open source Revenue: 66827000 Open source
20132013-12-31	Operating margin	-11.9%	Operating Income: -8029000 Open source Revenue: 67406000 Open source
20142014-12-31	Operating margin	-44.1%	Operating Income: -21043000 Open source Revenue: 47695000 Open source
20152015-12-31	Operating margin	-45.7%	Operating Income: -20726000 Open source Revenue: 45322000 Open source
20162016-12-31	Operating margin	-33.5%	Operating Income: -15868000 Open source Revenue: 47298000 Open source
20172017-12-31	Operating margin	-29.6%	Operating Income: -11005000 Open source Revenue: 37203000 Open source
20182018-12-31	Operating margin	-12.9%	Operating Income: -4348000 Open source Revenue: 33660000 Open source
20102010-12-31	Net margin	-4.2%	Net Income: -1778000 Open source Revenue: 42674000 Open source
20112011-12-31	Net margin	-55.8%	Net Income: -30015000 Open source Revenue: 53830000 Open source
20122012-12-31	Net margin	-1.1%	Net Income: -756000 Open source Revenue: 66827000 Open source
20132013-12-31	Net margin	-13.1%	Net Income: -8819000 Open source Revenue: 67406000 Open source
20142014-12-31	Net margin	-45.6%	Net Income: -21761000 Open source Revenue: 47695000 Open source
20152015-12-31	Net margin	-46.4%	Net Income: -21013000 Open source Revenue: 45322000 Open source
20162016-12-31	Net margin	-32.6%	Net Income: -15437000 Open source Revenue: 47298000 Open source
20172017-12-31	Net margin	-28%	Net Income: -10403000 Open source Revenue: 37203000 Open source
20182018-12-31	Net margin	-10.1%	Net Income: -3411000 Open source Revenue: 33660000 Open source
20102010-12-31	Free cash flow margin	-21.9%	Revenue: 42674000 Open source Operating Cash Flow: 1175000 Open source Capital Expenditure: 10517000 Open source
20112011-12-31	Free cash flow margin	-38.9%	Revenue: 53830000 Open source Operating Cash Flow: -8156000 Open source Capital Expenditure: 12806000 Open source
20122012-12-31	Free cash flow margin	-4.6%	Revenue: 66827000 Open source Operating Cash Flow: 3486000 Open source Capital Expenditure: 6560000 Open source
20132013-12-31	Free cash flow margin	-8.5%	Revenue: 67406000 Open source Operating Cash Flow: 7779000 Open source Capital Expenditure: 13534000 Open source
20142014-12-31	Free cash flow margin	-9.8%	Revenue: 47695000 Open source Operating Cash Flow: -1850000 Open source Capital Expenditure: 2815000 Open source
20152015-12-31	Free cash flow margin	-13.9%	Revenue: 45322000 Open source Operating Cash Flow: -4827000 Open source Capital Expenditure: 1452000 Open source
20162016-12-31	Free cash flow margin	-16.5%	Revenue: 47298000 Open source Operating Cash Flow: -5404000 Open source Capital Expenditure: 2381000 Open source
20172017-12-31	Free cash flow margin	-4.4%	Revenue: 37203000 Open source Operating Cash Flow: -873000 Open source Capital Expenditure: 777000 Open source
20182018-12-31	Free cash flow margin	13.8%	Revenue: 33660000 Open source Operating Cash Flow: 5938000 Open source Capital Expenditure: 1287000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 5.9M 2018

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Operating cash flow	1175000	Operating Cash Flow: 1175000 Open source
20112011-12-31	Operating cash flow	-8156000	Operating Cash Flow: -8156000 Open source
20122012-12-31	Operating cash flow	3486000	Operating Cash Flow: 3486000 Open source
20132013-12-31	Operating cash flow	7779000	Operating Cash Flow: 7779000 Open source
20142014-12-31	Operating cash flow	-1850000	Operating Cash Flow: -1850000 Open source
20152015-12-31	Operating cash flow	-4827000	Operating Cash Flow: -4827000 Open source
20162016-12-31	Operating cash flow	-5404000	Operating Cash Flow: -5404000 Open source
20172017-12-31	Operating cash flow	-873000	Operating Cash Flow: -873000 Open source
20182018-12-31	Operating cash flow	5938000	Operating Cash Flow: 5938000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 4.7M 2018

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Free cash flow	-9342000	Operating Cash Flow: 1175000 Open source Capital Expenditure: 10517000 Open source
20112011-12-31	Free cash flow	-20962000	Operating Cash Flow: -8156000 Open source Capital Expenditure: 12806000 Open source
20122012-12-31	Free cash flow	-3074000	Operating Cash Flow: 3486000 Open source Capital Expenditure: 6560000 Open source
20132013-12-31	Free cash flow	-5755000	Operating Cash Flow: 7779000 Open source Capital Expenditure: 13534000 Open source
20142014-12-31	Free cash flow	-4665000	Operating Cash Flow: -1850000 Open source Capital Expenditure: 2815000 Open source
20152015-12-31	Free cash flow	-6279000	Operating Cash Flow: -4827000 Open source Capital Expenditure: 1452000 Open source
20162016-12-31	Free cash flow	-7785000	Operating Cash Flow: -5404000 Open source Capital Expenditure: 2381000 Open source
20172017-12-31	Free cash flow	-1650000	Operating Cash Flow: -873000 Open source Capital Expenditure: 777000 Open source
20182018-12-31	Free cash flow	4651000	Operating Cash Flow: 5938000 Open source Capital Expenditure: 1287000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

20.8% 2018

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Liabilities / assets	Not reported	No source recorded
20112011-12-31	Liabilities / assets	37.3%	Total Liabilities: 47641000 Open source Total Assets: 127814000 Open source
20122012-12-31	Liabilities / assets	30.9%	Total Liabilities: 38168000 Open source Total Assets: 123685000 Open source
20132013-12-31	Liabilities / assets	31.8%	Total Liabilities: 39630000 Open source Total Assets: 124482000 Open source
20142014-12-31	Liabilities / assets	33.4%	Total Liabilities: 35172000 Open source Total Assets: 105437000 Open source
20152015-12-31	Liabilities / assets	19.5%	Total Liabilities: 13578000 Open source Total Assets: 69677000 Open source
20162016-12-31	Liabilities / assets	15.4%	Total Liabilities: 8172000 Open source Total Assets: 53168000 Open source
20172017-12-31	Liabilities / assets	18.6%	Total Liabilities: 8236000 Open source Total Assets: 44309000 Open source
20182018-12-31	Liabilities / assets	20.8%	Total Liabilities: 9009000 Open source Total Assets: 43393000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.48× 2018

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
20112011-12-31	Current assets / current liabilities	4.88×	Current Assets: 93927000 Open source Current Liabilities: 19262000 Open source
20122012-12-31	Current assets / current liabilities	2.4×	Current Assets: 89605000 Open source Current Liabilities: 37398000 Open source
20132013-12-31	Current assets / current liabilities	5.83×	Current Assets: 81352000 Open source Current Liabilities: 13956000 Open source
20142014-12-31	Current assets / current liabilities	7.13×	Current Assets: 72208000 Open source Current Liabilities: 10131000 Open source
20152015-12-31	Current assets / current liabilities	4.2×	Current Assets: 43054000 Open source Current Liabilities: 10244000 Open source
20162016-12-31	Current assets / current liabilities	6.51×	Current Assets: 32254000 Open source Current Liabilities: 4956000 Open source
20172017-12-31	Current assets / current liabilities	5.83×	Current Assets: 30738000 Open source Current Liabilities: 5269000 Open source
20182018-12-31	Current assets / current liabilities	5.48×	Current Assets: 34734000 Open source Current Liabilities: 6342000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	−USD 1.78 million Exact value Exact value: -1778000 USD 2010-01-01 – 2010-12-31: -1778000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2010-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -1778000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1778000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124113000056/imi-20121231.xml#819781 Filing: 000131124113000056 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 million Exact value Exact value: 1175000 USD 2010-01-01 – 2010-12-31: 1175000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2010-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: 1175000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1175000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124113000056/imi-20121231.xml#818724 Filing: 000131124113000056 The citation records this snapshot. The page link may show a newer release later.	USD 10.52 million Exact value Exact value: 10517000 USD 2010-01-01 – 2010-12-31: 10517000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2010-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 10517000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10517000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124113000056/imi-20121231.xml#939813 Filing: 000131124113000056 The citation records this snapshot. The page link may show a newer release later.	−USD 9.34 million Calculation and evidence 1175000 − 10517000 USD Exact free cash flow: -9342000 USD 2010-01-01 – 2010-12-31: 1175000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 10517000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2010-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -9342000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1175000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124113000056/imi-20121231.xml#818724 Filing: 000131124113000056 Input fundies:CapitalExpenditure: 10517000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124113000056/imi-20121231.xml#939813 Filing: 000131124113000056 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 30.02 million Exact value Exact value: -30015000 USD 2011-01-01 – 2011-12-31: -30015000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2011-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -30015000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30015000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124114000050/imi-20131231.xml#805296 Filing: 000131124114000050 The citation records this snapshot. The page link may show a newer release later.	−USD 8.16 million Exact value Exact value: -8156000 USD 2011-01-01 – 2011-12-31: -8156000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2011-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: -8156000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8156000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124114000050/imi-20131231.xml#804640 Filing: 000131124114000050 The citation records this snapshot. The page link may show a newer release later.	USD 12.81 million Exact value Exact value: 12806000 USD 2011-01-01 – 2011-12-31: 12806000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2011-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 12806000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12806000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124114000050/imi-20131231.xml#819526 Filing: 000131124114000050 The citation records this snapshot. The page link may show a newer release later.	−USD 20.96 million Calculation and evidence -8156000 − 12806000 USD Exact free cash flow: -20962000 USD 2011-01-01 – 2011-12-31: -8156000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 12806000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2011-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -20962000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8156000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124114000050/imi-20131231.xml#804640 Filing: 000131124114000050 Input fundies:CapitalExpenditure: 12806000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124114000050/imi-20131231.xml#819526 Filing: 000131124114000050 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 756,000 Exact value Exact value: -756000 USD 2012-01-01 – 2012-12-31: -756000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2012-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -756000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -756000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#242545 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.	USD 3.49 million Exact value Exact value: 3486000 USD 2012-01-01 – 2012-12-31: 3486000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2012-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: 3486000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3486000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#241794 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.	USD 6.56 million Exact value Exact value: 6560000 USD 2012-01-01 – 2012-12-31: 6560000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2012-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 6560000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6560000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#254905 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.	−USD 3.07 million Calculation and evidence 3486000 − 6560000 USD Exact free cash flow: -3074000 USD 2012-01-01 – 2012-12-31: 3486000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 6560000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2012-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -3074000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3486000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#241794 Filing: 000131124115000022 Input fundies:CapitalExpenditure: 6560000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#254905 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 8.82 million Exact value Exact value: -8819000 USD 2013-01-01 – 2013-12-31: -8819000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2013-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -8819000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8819000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#243129 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.	USD 7.78 million Exact value Exact value: 7779000 USD 2013-01-01 – 2013-12-31: 7779000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2013-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: 7779000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7779000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#242044 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.	USD 13.53 million Exact value Exact value: 13534000 USD 2013-01-01 – 2013-12-31: 13534000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2013-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 13534000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13534000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#255115 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.	−USD 5.76 million Calculation and evidence 7779000 − 13534000 USD Exact free cash flow: -5755000 USD 2013-01-01 – 2013-12-31: 7779000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 13534000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2013-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -5755000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7779000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#242044 Filing: 000131124115000022 Input fundies:CapitalExpenditure: 13534000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000131124115000022/imi-20141231.xml#255115 Filing: 000131124115000022 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 21.76 million Exact value Exact value: -21761000 USD 2014-01-01 – 2014-12-31: -21761000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2014-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -21761000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21761000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#127189 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.	−USD 1.85 million Exact value Exact value: -1850000 USD 2014-01-01 – 2014-12-31: -1850000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2014-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: -1850000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1850000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#153533 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.	USD 2.82 million Exact value Exact value: 2815000 USD 2014-01-01 – 2014-12-31: 2815000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2014-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 2815000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2815000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#155415 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.	−USD 4.67 million Calculation and evidence -1850000 − 2815000 USD Exact free cash flow: -4665000 USD 2014-01-01 – 2014-12-31: -1850000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 2815000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2014-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -4665000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1850000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#153533 Filing: 000156459017003326 Input fundies:CapitalExpenditure: 2815000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#155415 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 21.01 million Exact value Exact value: -21013000 USD 2015-01-01 – 2015-12-31: -21013000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2015-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -21013000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21013000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#127035 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.	−USD 4.83 million Exact value Exact value: -4827000 USD 2015-01-01 – 2015-12-31: -4827000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2015-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: -4827000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4827000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#153282 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.	USD 1.45 million Exact value Exact value: 1452000 USD 2015-01-01 – 2015-12-31: 1452000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2015-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 1452000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1452000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#155205 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.	−USD 6.28 million Calculation and evidence -4827000 − 1452000 USD Exact free cash flow: -6279000 USD 2015-01-01 – 2015-12-31: -4827000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1452000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2015-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -6279000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4827000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#153282 Filing: 000156459017003326 Input fundies:CapitalExpenditure: 1452000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459017003326/imi-20161231.xml#155205 Filing: 000156459017003326 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 15.44 million Exact value Exact value: -15437000 USD 2016-01-01 – 2016-12-31: -15437000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2016-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -15437000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15437000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459018004255/imi-20171231.xml#105472 Filing: 000156459018004255 The citation records this snapshot. The page link may show a newer release later.	−USD 5.4 million Exact value Exact value: -5404000 USD 2016-01-01 – 2016-12-31: -5404000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2016-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: -5404000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5404000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459018004255/imi-20171231.xml#123296 Filing: 000156459018004255 The citation records this snapshot. The page link may show a newer release later.	USD 2.38 million Exact value Exact value: 2381000 USD 2016-01-01 – 2016-12-31: 2381000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2016-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 2381000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2381000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459018004255/imi-20171231.xml#124564 Filing: 000156459018004255 The citation records this snapshot. The page link may show a newer release later.	−USD 7.79 million Calculation and evidence -5404000 − 2381000 USD Exact free cash flow: -7785000 USD 2016-01-01 – 2016-12-31: -5404000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 2381000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2016-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -7785000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5404000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459018004255/imi-20171231.xml#123296 Filing: 000156459018004255 Input fundies:CapitalExpenditure: 2381000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459018004255/imi-20171231.xml#124564 Filing: 000156459018004255 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 10.4 million Exact value Exact value: -10403000 USD 2017-01-01 – 2017-12-31: -10403000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2017-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -10403000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10403000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#118856 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.	−USD 873,000 Exact value Exact value: -873000 USD 2017-01-01 – 2017-12-31: -873000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2017-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: -873000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -873000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#135781 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.	USD 777,000 Exact value Exact value: 777000 USD 2017-01-01 – 2017-12-31: 777000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2017-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 777000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 777000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#137009 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.	−USD 1.65 million Calculation and evidence -873000 − 777000 USD Exact free cash flow: -1650000 USD 2017-01-01 – 2017-12-31: -873000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 777000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2017-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: -1650000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -873000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#135781 Filing: 000156459019007009 Input fundies:CapitalExpenditure: 777000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#137009 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 3.41 million Exact value Exact value: -3411000 USD 2018-01-01 – 2018-12-31: -3411000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Net Income: -3411000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3411000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#118703 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.	USD 5.94 million Exact value Exact value: 5938000 USD 2018-01-01 – 2018-12-31: 5938000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Operating Cash Flow: 5938000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5938000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#135571 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.	USD 1.29 million Exact value Exact value: 1287000 USD 2018-01-01 – 2018-12-31: 1287000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Capital Expenditure: 1287000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1287000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#136799 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.	USD 4.65 million Calculation and evidence 5938000 − 1287000 USD Exact free cash flow: 4651000 USD 2018-01-01 – 2018-12-31: 5938000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1287000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERMOLECULAR INC · 2018-12-31 INTERMOLECULAR INC (edgar:1311241) Free cash flow: 4651000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:18:58Z Snapshot: f4a5249915bcda4539903b298203dfcad4ee64b38399c1c6091bab7c723f3140 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311241?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5938000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#135571 Filing: 000156459019007009 Input fundies:CapitalExpenditure: 1287000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311241/000156459019007009/imi-20181231.xml#136799 Filing: 000156459019007009 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

38 filings · 2,822 latest values · 2,822 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001311241, 1311241, IMI, edgar:1311241

Also known as INTERMOLECULAR INC

INTERMOLECULAR INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2018 2018-01-01 – 2018-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation